CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Finally, combination of PD and ATO significantly reduced the clonogenic potential of TKIs-resistant Ph+ cell lines and primary CML CD34+ cells, as compared to either agent alone (Fig. 1D, E and Supplementary Fig. 2).